Nonprofit · EIN 39-1372542
VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC
Tax-exempt · MILWAUKEE, WI 53201
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $17,317,531 | $12,431,033 | $4,886,498 | $142,624,739 | $808,137 | $141,816,602 |
| December 31, 2023 | 990 | $10,946,946 | $11,357,497 | -$410,551 | $133,873,238 | $1,501,991 | $132,371,247 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $7,583,828
- Program service revenue
- $0
- Investment income
- $9,242,860
- Royalties
- $530,284
- Net gain from sales of assets
- $5,927,824
- Net income from fundraising events
- -$39,441
- Other revenue
- $490,843
Expenses
- Grants and similar amounts paid
- $10,774,042
- Compensation of officers, directors and key employees
- $254,762
- Other salaries and wages
- $631,685
- Salaries, compensation and benefits (total)
- $1,096,354
- Professional fundraising fees
- $40,610
- Legal fees
- $99,190
- Occupancy
- $1,050
- Travel
- $12,661
- Depreciation
- $3,866
- Program services (functional)
- $10,774,042
- Management and general (functional)
- $676,145
- Fundraising (functional)
- $980,846
Balance sheet and other
- Total assets, start of year
- $133,873,238
- Total assets, end of year
- $142,624,739
- Total liabilities, end of year
- $808,137
- Net assets, end of year
- $141,816,602
- Publicly traded securities
- $100,917,738
- Net assets without donor restrictions
- $129,211,445
- Net assets with donor restrictions
- $12,605,157
- Gross unrelated business income
- -$18,218
- Gross receipts
- $55,794,093
- Employees
- 6
- Volunteers
- 16
- Year formed
- 1981
- State of legal domicile
- WI
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| CHRIS MISKEL | PRESIDENT & CEO Trustee or director, Officer | 1 | $0 | $1,622,596 | $57,669 |
| BART REUTER | EVP & GENERAL COUNSEL Officer | 1 | $0 | $861,600 | $66,046 |
| ANTHONY WATKINS | EVP&CFO-THRU 3/24;BUS DEV-AS OF 3/24 Officer | 1 | $0 | $748,711 | $29,876 |
| MICHAEL DEININGER MD | EVP & CHIEF SCIENTIFIC OFFICER Officer | 3 | $33,530 | $637,080 | $39,231 |
| MATTHEW ANDERSON MD | EVP & CHIEF MED. OFF. - AS OF 7/24 Officer | 1 | $0 | $471,868 | $65,850 |
| DEREK TYUS | EVP & CHIEF FINANCIAL OFF. - AS 3/24 Officer | 1 | $0 | $452,304 | $48,353 |
| BARBARA BRYANT | EVP & CHIEF MED. OFF. - THRU 8/24 Officer | 1 | $0 | $447,822 | $25,848 |
| JOHN MABRY | DIRECTOR TECH TRANSFER Highest-paid employee | 55 | $199,236 | $0 | $55,178 |
| KELLEY MCCASKILL | VP OF PHILANTHROPY Officer | 55 | $182,039 | $0 | $37,232 |
| ALBERTO G HUERTA | DIRECTOR FDN DEVELOPMENT Highest-paid employee | 55 | $110,578 | $0 | $14,786 |
| JULIA SYBURG | CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| DIXON BENZ II | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| ANDY ANDERSON MD | SECRETARY Trustee or director, Officer | 1 | $0 | $0 | $0 |
| GUY CRANE | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
| SAM BRADT | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
11 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| LOUISE CROWLEY | BOARD MEMBER - THRU 10/24 Trustee or director | 1 | $0 |
| WILLIAM CROWLEY | BOARD MEMBER Trustee or director | 1 | $0 |
| JASON DVORAK | BOARD MEMBER Trustee or director | 1 | $0 |
| FRED GEILFUSS | BOARD MEMBER Trustee or director | 1 | $0 |
| EMERY HARLAN | BOARD MEMBER Trustee or director | 1 | $0 |
| KATHY KLEIN | BOARD MEMBER Trustee or director | 1 | $0 |
| ROBERT H MANEGOLD | BOARD MEMBER Trustee or director | 1 | $0 |
| ABHISHEK PULAKANTI | BOARD MEMBER Trustee or director | 1 | $0 |
| JOHN R RAYMOND SR MD | BOARD MEMBER Trustee or director | 1 | $0 |
| JOHAN SEGERDAHL | BOARD MEMBER Trustee or director | 1 | $0 |
| SUZY STEMPER | BOARD MEMBER - THRU 8/24 Trustee or director | 1 | $0 |
990 for the year ended December 31, 2023: 26 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| CHRIS MISKEL | PRESIDENT & CEO Trustee or director, Officer | 1 | $0 | $1,425,101 | $55,375 |
| BART REUTER | EVP & GENERAL COUNSEL Officer | 1 | $0 | $720,940 | $64,225 |
| ANTHONY WATKINS | EVP & CHIEF FINANCIAL OFFICER Officer | 1 | $0 | $741,823 | $40,131 |
| MICHAEL DEININGER MD | EVP & CHIEF SCIENTIFIC OFFICER Officer | 3 | $32,182 | $611,478 | $39,453 |
| BARBARA BRYANT | EVP & CHIEF MED OFFICER Officer | 1 | $0 | $546,023 | $25,848 |
| JOHN MABRY | DIRECTOR TECH TRANSFER Highest-paid employee | 55 | $181,451 | $0 | $53,512 |
| KELLEY MCCASKILL | VP OF PHILANTHROPY Officer | 55 | $191,356 | $0 | $36,503 |
| ALBERTO G HUERTA | DIRECTOR FDN DEVELOPMENT Highest-paid employee | 55 | $108,153 | $0 | $17,186 |
| JULIA SYBURG | CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| DIXON BENZ II | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| ANDY ANDERSON MD | SECRETARY Trustee or director, Officer | 1 | $0 | $0 | $0 |
| GUY CRANE | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
| SAM BRADT | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| LOUISE CROWLEY | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| WILLIAM CROWLEY | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| JASON DVORAK | BOARD MEMBER - AS OF 9/2023 Trustee or director | 1 | $0 | $0 | $0 |
| FRED GEILFUSS | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| EMERY HARLAN | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| THOMAS HAUSKE JR | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| KATHY KLEIN | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| ROBERT H MANEGOLD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| ABHISHEK PULAKANTI | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| JOHN R RAYMOND SR MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| JOHAN SEGERDAHL | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SUZY STEMPER | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| MICHAEL H WHITE | BOARD MEMBER - THRU 6/2023 Trustee or director | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- PO BOX 2178, MILWAUKEE, WI 53201-2178
- In care of
- % PAUL MATSON
- Principal officer (990 for 2024)
- CHRIS MISKEL, PO BOX 2178, MILWAUKEE, WI 532012178
- Signed the 990
- CHRIS MISKEL, PRESIDENT & CEO
- Phone
- (414) 933-5000
- Website
- WWW.VERSITI.ORG
- Return prepared by
- GRANT THORNTON ADVISORS LLC
Mission
(SEE SCHEDULE O)
Program accomplishments
- THE VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION (VBRIF) ADVANCES SCIENTIFIC DISCOVERY AND PATIENT CARE THROUGH COMPREHENSIVE SUPPORT OF BLOOD-RELATED RESEARCH, EDUCATION, AND COMMUNITY ENGAGEMENT PROGRAMS. ROOTED IN ITS NONPROFIT MISSION, THE VBRIF ENABLES GROUNDBREAKING BLOOD RESEARCH WHILE FOSTERING THE NEXT GENERATION OF SCIENTISTS AND IMPROVING THE LIVES OF PATIENTS AFFLICTED BY BLOOD DISORDERS. IN 2024, VBRIF-SUPPORTED RESEARCHERS PUBLISHED 122 PEER-REVIEWED MANUSCRIPTS WITH 45 FEATURING VBRI FACULTY AS LEAD OR SENIOR AUTHORS, INCLUDING 5 PUBLICATIONS IN JOURNALS WITH IMPACT FACTORS EXCEEDING 30. THE VBRIF'S RESEARCH SPANS 5 MAJOR PROGRAMS: TRANSFUSION MEDICINE, VASCULAR BIOLOGY, AND CELLULAR THERAPY; THROMBOSIS AND HEMOSTASIS; STEM CELL BIOLOGY AND HEMATOPOIESIS; IMMUNOLOGY; (CONTINUED IN SCHEDULE O) AND TRANSLATIONAL HEMATOLOGY. VBRIF GRANT TEAMS PROCESSED APPROXIMATELY $41M IN NEW MULTI-YEAR GRANTS AND SUBMITTED 112 PROPOSALS TOTALING $140.13M IN 2024. LEADERSHIP: VBRIF SUPPORTS VERSITI'S LEADERSHIP IN VENUS (VENOUS THROMBOEMBOLISM NETWORK US) AND REDS-IV-P (RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY), NATIONAL PROGRAMS ADVANCING THROMBOSIS TREATMENT AND BLOOD TRANSFUSION SAFETY. VBRIF FUNDS SPECIALIZED SHARED RESOURCES INCLUDING BIOINFORMATICS, FLOW CYTOMETRY, AND MOLECULAR BIOLOGY CORES. VBRIF ALSO CO-LEADS THE MRMC HEMATOLOGY BIOREPOSITORY WHICH PROVIDES ANNOTATED BIOLOGICAL SAMPLES FOR BIOMARKER DISCOVERY. INFRASTRUCTURE AND EDUCATION: OPERATING IN AN 82,000 SQUARE-FOOT FACILITY, THE VBRIF SUPPORTED 213 RESEARCH STAFF, INCLUDING 35 INVESTIGATORS, IN 2024. EDUCATIONAL INITIATIVES INCLUDE GRADUATE TRAINING, RESEARCH SYMPOSIA, AND COLLABORATIVE PARTNERSHIPS IN THE MILWAUKEE REGIONAL MEDICAL CENTER. THE VBRIF IS ALSO UNDERTAKING A $79M FACILITY EXPANSION WITH STATE FUNDING AND PRIVATE PHILANTHROPIC SUPPORT. THE INITIATIVE WILL GROW RESEARCH CAPACITY TO 167K SQUARE FEET AND STRENGTHEN WISCONSIN'S ROLE AS A GLOBAL CENTER FOR BLOOD RESEARCH. BY SUPPORTING RESEARCH, EDUCATION, AND SCIENTIFIC COLLABORATION, VBRIF CATALYZES DISCOVERY AND IMPROVED PATIENT CARE IN HEMATOLOGY AND TRANSFUSION MEDICINE.Expenses $10,689,610 · grants $10,689,610
- VBRIF SUPPORTS THE EFFORTS OF ITS SUPPORTED ORGANIZATIONS, WHICH FURTHER THE IMPORTANT CAUSES OF BLOOD AND ORGAN DONATIONS AND RESEARCH.Expenses $84,432 · grants $84,432
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 39-1372542
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Supporting organization, Type II
- Donations deductible (Pub 78)
- Supporting organization, 50% limit
- Exempt since
- 1981
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Health care (E50)
- Assets (IRS master file)
- $142,624,739
- Income (IRS master file)
- $55,794,093
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $17,317,531 | $12,431,033 | $142,624,739 | IRS |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $10,946,946 | $11,357,497 | $133,873,238 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $9,619,286 | $9,805,415 | $123,463,060 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-T | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-T | December 2020 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 39-1372542).
Questions about VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC
- What is the EIN of VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC?
- The employer identification number (EIN) of VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC is 39-1372542.
- Is VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1981.
- Are donations to VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Supporting organization, 50% limit).
- Which annual return does VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC?
- The 990 for the year ended December 31, 2024 names CHRIS MISKEL.
- Who are the officers and directors of VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC?
- The 990 for the year ended December 31, 2024 lists 26 people; 4 received compensation from the organization.
- How much revenue does VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $17,317,531, expenses of $12,431,033 and total assets of $142,624,739 at year end.
Other nonprofits in MILWAUKEE
- FROEDTERT MEMORIAL LUTHERAN HOSPITAL INC EIN 39-6105970 · last filed 990 for 2025
- FROEDTERT THEDACARE HEALTH INC EIN 39-2014409 · last filed 990 for 2025
- CHILDRENS HOSPITAL OF WISCONSIN INC EIN 39-0812532 · last filed 990 for 2024
- CHORUS COMMUNITY HEALTH PLANS INC EIN 27-1494977 · last filed 990 for 2024
- CHILDRENS HOSPITAL AND HEALTH SYSTEM INC EIN 39-1500074 · last filed 990 for 2024
- VERSITI BLOOD HEALTH INC EIN 39-0807235 · last filed 990 for 2024
- CHILDRENS SPECIALTY GROUP INC EIN 39-1990012 · last filed 990 for 2024
- AURORA HEALTH CARE INC EIN 39-1442285 · last filed 990 for 2024